Interclean Shanghai

Toshiba expands availability of next generation advanced image processing for Infix-i Line

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Toshiba America Medical Systems, Inc. is expanding the availability of Next Generation Advanced Image Processing (AIP) to more systems in the Toshiba InfinixTM-i product line.

Robert Micer, director, X-ray Vascular Business Unit, Toshiba said, Next Generation AIP has made an immediate impact on patient care in facilities across the country, so we are expanding its availability to additional systems in the Infinix line. This new processor produces better image quality, reduces background noise, and improves device and vessel visualization to allow physicians to improve workflow and provide better patient care during interventional procedures.

Toshiba’s Next Generation AIP feature improves patient care by increasing the quality, sharpness, and image contrast during interventional procedures. This proprietary technology has virtually eliminated image lag, benefiting clinicians while guiding and deploying devices during fluoroscopy. Next Generation AIP further increases image clarity during interventional procedures to create a safer, more time-efficient exam for the patient by reducing the possibility of having to re-image the patient if the image is not clear. Next Generation AIP is particularly beneficial for stent implementation, patients with rapid heart rates or small tortuous arteries, bariatric patients and emergency situations.

Next Generation AIP is available now on the Infinix-i systems with mid-and large-sized flat panel detectors, optimizing imaging for cardiac, vascular and neuro procedures.

Toshiba will showcase Next Generation AIP at this year’s Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in San Francisco, Sept. 21 – Sept. 25, 2009 (Booth #705).

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »